Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Clinical Pharmacology and Therapeutics
|
December 20, 2007
Monoamine oxidase inhibition for tobacco pharmacotherapy
T P George, A H Weinberger
Clinical Pharmacology and Therapeutics
|
July 24, 2009
Clozapine, GABA(B), and the treatment of resistant schizophrenia
Z J Daskalakis, T P George
The American Journal of Psychiatry
|
October 1, 1996
Hypertension after initiation of clozapine
T P George, L C Winther
Schizophrenia Bulletin
|
January 1, 1997
Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues
D M Ziedonis, T P George
Archives of General Psychiatry
|
November 1, 1996
Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy
T P George, M W Spence
Clinical Pharmacology and Therapeutics
|
July 2, 2016
Understanding the Link Between Cannabinoids and Psychosis
R A Rabin, T P George
Biological Psychiatry
|
March 1, 1996
Possible serotonin syndrome with trazodone addition to fluoxetine
T P George, L S Godleski
Brain Research
|
September 5, 1998
Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress
T P George, C D Verrico, R H Roth
Pharmacology, Biochemistry, and Behavior
|
September 6, 2000
Gender differences in learned helplessness behavior are influenced by genetic background
B J Caldarone, T P George, V Zachariou, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 28, 2000
Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms
T P George, C D Verrico, L Xu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Clinical Pharmacology and Therapeutics
|
December 20, 2007
Monoamine oxidase inhibition for tobacco pharmacotherapy
T P George, A H Weinberger
Clinical Pharmacology and Therapeutics
|
July 24, 2009
Clozapine, GABA(B), and the treatment of resistant schizophrenia
Z J Daskalakis, T P George
The American Journal of Psychiatry
|
October 1, 1996
Hypertension after initiation of clozapine
T P George, L C Winther
Schizophrenia Bulletin
|
January 1, 1997
Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues
D M Ziedonis, T P George
Archives of General Psychiatry
|
November 1, 1996
Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy
T P George, M W Spence
Clinical Pharmacology and Therapeutics
|
July 2, 2016
Understanding the Link Between Cannabinoids and Psychosis
R A Rabin, T P George
Biological Psychiatry
|
March 1, 1996
Possible serotonin syndrome with trazodone addition to fluoxetine
T P George, L S Godleski
Brain Research
|
September 5, 1998
Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress
T P George, C D Verrico, R H Roth
Pharmacology, Biochemistry, and Behavior
|
September 6, 2000
Gender differences in learned helplessness behavior are influenced by genetic background
B J Caldarone, T P George, V Zachariou, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 28, 2000
Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms
T P George, C D Verrico, L Xu, et al.
Page
of 3